Post-approval studies (Phase 4)WithdrawnNCT03546400
What this trial is testing
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Pfizer